A TRIAL TO EVALUATE THE SAFETY, TOLERABILITY, PHARMACOKINETICS, AND EFFICACY OF SHR-A1904 IN SUBJECTS WITH ADVANCED SOLID TUMORS
Clinical trial NCT05277168 · RECRUITING
Trial details
- NCT number
- NCT05277168
- Sponsor
- Jiangsu HengRui Medicine Co., Ltd.
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-05-30
- Primary completion
- 2026-05-01
- Enrollment
- 83
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.